Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol versus albumin for prevention of intradialytic hypotension during prolonged hemodialysis in sepsis-associated acute kidney injury
RBR-749vzfzPhase 4Recruiting
- Sponsor
- Departamento de Suporte às Unidades de Saúde
- Start
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human) and Bronchitol in acute kidney failure (AKF) (3 arms), sponsored by Departamento de Suporte às Unidades de Saúde. Started Apr 2025; status: recruiting.
02
Drugs
albumin (human)Bronchitol
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on RBR-749vzfz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-749vzfz.